Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT07174336 2026-03-06

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Phase 3 Recruiting

920 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01560416 2026-03-03

Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

Phase 2 Completed

50 enrolled 14 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT05501886 2026-02-10

VIKTORIA-1

Phase 3 Active not recruiting

701 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT05169567 2026-01-16

postMONARCH

Phase 3 Active not recruiting

368 enrolled 14 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT05735080 2025-09-19

INX-315-01

Phase 1/2 Recruiting

150 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms

NCT07163481 2025-09-16

SoGreat

Phase 1 Not yet recruiting

12 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04300790 2025-07-29

METALLICA

Phase 2 Completed

69 enrolled

BreastEndocrine

Breast Neoplasms, Hyperglycemia, Neoplasm Metastasis, Multiple Endocrine Neoplasia Type 1

NCT04975308 2025-07-11

EMBER-3

Phase 3 Active not recruiting

874 enrolled 29 charts 1 FDA

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06253195 2025-06-05

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Phase 1 Active not recruiting

33 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01441947 2025-05-25

Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

Phase 2 Completed

68 enrolled 11 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT03854903 2025-02-06

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

Phase 1 Completed

19 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02536742 2024-02-26

PYTHIA

Phase 2 Completed

124 enrolled 10 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04901299 2023-08-01

HER2-Signal

Phase 2 Withdrawn

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02894398 2023-03-13

INGE-B

Phase 2 Completed

388 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01655225 2022-04-08

A Study of LY3023414 in Participants With Advanced Cancer

Phase 1 Completed

156 enrolled

BreastLymphoidOther solid neoplasmThoracic

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Lymphoma, Non-Hodgkin, Mesothelioma, Neoplasm Metastasis

NCT03220178 2022-01-06

PRECYCLE

Phase 4 Terminated

532 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04498520 2021-05-18

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

Phase 1 Withdrawn

BreastGynecologic

Breast Neoplasms, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Carcinoma, Endometrioid

NCT01610284 2020-08-25

BELLE-2

Phase 3 Completed

1,147 enrolled 20 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02690480 2020-02-05

FLIPPER

Phase 2 Unknown

189 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01633060 2019-01-30

BELLE-3

Phase 3 Terminated

432 enrolled 20 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT03560856 2018-06-18

PALPETBIO

Phase 2 Unknown

54 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00752986 2016-12-05

ZACFAST

Phase 2 Terminated

39 enrolled 7 charts

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02383030 2016-06-15

FUMANCE

Phase 3 Unknown

156 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02404051 2016-06-15

FEVEX

Phase 3 Unknown

745 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00534417 2013-02-01

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

Phase 2 Completed

41 enrolled 13 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

NCT00241449 2012-06-06

A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

Phase 3 Completed

51 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01399086 2012-03-13

Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer

Completed

140 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Neoplasms

Clinical Trials

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

Fulvestrant With or Without Ganetespib in HR+ Breast Cancer

VIKTORIA-1

postMONARCH

INX-315-01

SoGreat

METALLICA

EMBER-3

BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

Cabozantinib in Women With Metastatic Hormone-Receptor-Positive Breast Cancer

WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor

PYTHIA

HER2-Signal

INGE-B

A Study of LY3023414 in Participants With Advanced Cancer

PRECYCLE

Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer

BELLE-2

FLIPPER

BELLE-3

PALPETBIO

ZACFAST

FUMANCE

FEVEX

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer

Fulvestrant in Postmenopausal Patients With Metastatic Breast Cancer